Skip to content
Pill with imprint 295, pink, oval, 17 mm (Trandolapril and Verapamil Hydrochloride Trandolapril 2 mg / Verapamil Hydrochloride 180 mg)

“Trandolapril and Verapamil Hydrochloride Extended-Release Tablets, 2 mg/180 mg are supplied as pink colored, oval, biconvex, film-coated tablets with '295' debossed on one side and plain on the other side containing 2 mg trandolapril, USP in an immediate-release form and 180 mg verapamil hydrochloride, USP in an extended-release form”

295 pill

Pill with imprint 295 is pink, oval, 17 mm and has been identified as Trandolapril and Verapamil Hydrochloride 2 mg / 180 mg. It is used for high blood pressure. It is supplied by Glenmark Pharmaceuticals Inc., USA.

Trandolapril and Verapamil Hydrochloride 2 mg / 180 mg

Imprint
295
Strength
Trandolapril 2 mg / Verapamil Hydrochloride 180 mg
Used for
High blood pressure
Color
Pink
Shape
Oval
Size
17 mm
Score
No score line
Form
Tablet, film coated, extended release
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Drug class
ACE inhibitor (blood pressure and heart medicine)
NDC
68462-295, 68462-295-01, 68462-295-10, 68462-295-90

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Glenmark Pharmaceuticals Inc., USA.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Trandolapril and Verapamil Hydrochloride pills and guides

What is Trandolapril and Verapamil Hydrochloride used for?

Trandolapril and Verapamil Hydrochloride is used for high blood pressure.

Medicine type
ACE inhibitor (blood pressure and heart medicine); calcium channel blocker (blood pressure and heart medicine)
Official uses from the US prescribing label

Trandolapril and verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension.

This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ).

In using trandolapril and verapamil hydrochloride extended-release tablets, consideration should be given to the fact that an angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that trandolapril does not have similar risk (see WARNINGS - Neutropenia/Agranulocytosis ).

From the FDA-approved label on DailyMed (published Jan 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 295 and the other side is plain.
  • It is pink, oval, 17 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Trandolapril, Verapamil Hydrochloride

Inactive: Silicon Dioxide, Starch, Corn, Croscarmellose Sodium, Ferric Oxide Red, Hypromellose, Unspecified, Lactose Monohydrate, Povidone, Unspecified, Sodium Alginate, Sodium Stearyl Fumarate, Magnesium Stearate, Microcrystalline Cellulose, Titanium Dioxide, Polyethylene Glycol 400, Fd&c Blue No. 2

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Trandolapril and Verapamil Hydrochloride pills